Rajesh Shukla

SICKLE-CELL TRAIT IN CENTRAL INDIA

Rajesh Shukla, B. R. Solanki · The Lancet · 1958 · 66 citations

Medicine, Genetics, Hematology +10

A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1

David B. Huang, William O’Riordan, J. Scott Overcash et al. · Clinical Infectious Diseases · 2017 · 49 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study)

Thomas L Holland, William O’Riordan, Alison J. McManus et al. · Antimicrobial Agents and Chemotherapy · 2018 · 38 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Sickle Cell Disease in India

Rajesh Shukla, B. R. Solanki, Altaf Parande · Blood · 1958 · 17 citations · Full text

Medicine, Hematology, Hematopathology +8